Researchers at Fred Hutchinson Cancer Research Center and the University of Washington, Seattle have discovered a number of potential key drivers?recurrent genetic mistakes?common to advanced prostate cancer that may contribute to disease progression.
Men over 75 years of age are being undertreated for prostate cancer, while patients with a single comorbid condition such as peripheral vascular disease are being overtreated and doing much more poorly than expected, say researchers from UCLA?s Jonsson Comprehensive Cancer Center.
The future of patient-centered urologic care depends on collaboration with allied advocacy affiliates.
This list of National Institutes of Health trials is derived from the NIH's database and includes phase III and IV bladder cancer trials and phase II overactive bladder trials. This list is current as of Sept. 15, 2011.
Near infrared fluorescence imaging of intravenous indocyanine green during robot-assisted laparoscopic partial nephrectomy can accurately identify the renal vasculature and successfully differentiate tumor from surrounding parenchyma.
Serum testosterone concentration rises in a predictable manner after implantation of extended-release testosterone pellets (Testopel), and the dose response is not impacted by the patient's body mass index.
Accumulating data from patients with progressive, castration-resistant prostate cancer enrolled in a phase I-II study of MDV3100 show this novel antiandrogen has durable antitumor activity in both pre- and post-chemotherapy populations.
An investigational minimally invasive urethral expansion system achieved significant and durable improvement in BPH/lower urinary tract symptoms in a multicenter study.
By analyzing work relative value units (RVUs) in a number of urology groups, we have verified that they have had an approximate 10% decrease in income while generating the same number of work RVUs.
The newest urology products and services from US Urology, Cook Medical, Abbott Laboratories, the Medical Collaboration Network, the Agency for Healthcare Research and Quality, the AUA Foundation, and Trophikos, LLC.
A team at the University of Washington School of Medicine and Applied Physics Lab, Seattle, is refining prototype technology that should allow extracorporeal ultrasound to image and, more importantly, move stones in a kidney as if they were being nudged gently by a pool cue.
Those of us who are not employed by a hospital or other entity remain small business men/women, and therefore need to be as attentive to the business aspect of our practices as we are to the clinical care we offer our patients.
Repeat injections of onabotulinumtoxinA (Botox) over the long term are showing value in patients with interstitial cystitis.
The investigational selective beta3-adrenoceptor agonist mirabegron effectively improves symptoms of overactive bladder and is very safe and well tolerated.
An organization's mission is more than its day-to-day activities. Writing a new mission statement can be a refreshing opportunity to step away from the busywork and refocus on what matters most.
Our commitment to our patients must be sustained. As a result, LESS is in everyone's future in one form or another.
After seeing physicians in Maine ask legislators to delay a bill limiting medical liability, speculation is that because doctors who have joined large groups or hospital practices have fewer concerns related to running a business-eg, meeting payroll, hiring staff, malpractice premiums, and meeting overhead-their priorities might be shifting.
Robotic pyeloplasty demonstrated several operative and outcome advantages over the laparoscopic technique in patients with ureteropelvic junction (UPJ) obstruction.
Adding vibrotactile feedback to robotic minimally invasive surgery can increase awareness of tool actions and surgeons' perceived ability to concentrate.
Urologists at Cleveland Clinic have undertaken a pilot program involving modification of a commercial electronic medical record (EMR) system to facilitate clinical research and clinical practice outcomes analysis in a way that overcomes the obstacles presented by the record-keeping technology.
Urologists want Medicare to be run efficiently and be easy for patients to navigate, regardless of whether it's run by the government or private industry.
Daniel P. Petrylak, MD, explains the role of new first- and second-line prostate cancer therapies, how they address previously unmet needs, and their associated side effects.
Before jumping on the gold bandwagon, it is important to understand the market factors that impact gold pricing, and how this unique commodity may or may not fit into your overall investment portfolio.
Laparoendoscopic single-site surgery (LESS) has evolved to the point that a broad range of urologic procedures can be performed effectively and safely by applying different techniques.
Physician organizations nationwide, including the AUA, have united in opposition to many provisions of a plan by the Centers for Medicare & Medicaid Services to sell Medicare claims data to qualified businesses that would generate public reports rating physician performance in each episode of care.
Analyses of data from a large series of men undergoing microdissection testicular sperm extraction (mTESE) showed that among patients who had no sperm found in the OR, 7% had sperm identified following tissue digestion and extensive searching in the laboratory.
Utilization trends for minimally invasive treatment of prostate cancer appear to be similar across sites of service, a recent study indicates.
Seasonal variations in kidney stone incidence appear to be reflected in Google search engine queries, according to researchers at the University of California, San Francisco.
Long-term use of degarelix (Firmagon), a gonadotropin-releasing hormone therapy approved for the treatment of advanced prostate cancer in both Europe and the United States, continues to be effective and well tolerated beyond 3 years, according a recent study.